For now, though, the story out of Marlborough remains focused on relentless growth: Revenue is expected to rise this year by ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held medical device ...

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide ...

Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

On Wednesday, Boston Scientific Corporation (BSX) stock saw a modest uptick, ending the day at $90.75 which represents a slight increase of $0.54 or 0.60% from the prior close of $90.21. The stock ...

Boston Scientific has the Maple Grove Planning Commission’s support for a proposed building addition on the company’s Weaver ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable ...

Finance & Commerce reports that Boston Scientific (NYSE:BSX) took the next step toward a massive expansion in Maple Grove, Minnesota.

BOS Nation Football Club may be a name of the past before Boston’s professional women’s soccer team even takes the pitch.